Plant ID: NPO15738
Plant Latin Name: Heracleum mantegazzianum
Taxonomy Genus: Heracleum
Taxonomy Family: Apiaceae
NCBI TaxonomyDB:
380077
Plant-of-the-World-Online:
n.a.
China
MAPK1; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2A13 | Cytochrome P450 2A13 | Q16696 | CHEMBL3542436 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 9.052E-14 | 6.570E-10 | CYP1A2, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 2.603E-13 | 1.417E-09 | CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 5.238E-13 | 2.281E-09 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.142E-12 | 3.551E-09 | CYP1A2, CYP2A13, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 2.044E-12 | 4.945E-09 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.985E-12 | 5.909E-09 | CYP1A2, CYP2A6, CYP2C19, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 3.605E-11 | 6.541E-08 | CYP1A2, CYP2A13, CYP2A6, CYP2C19 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 5.332E-11 | 8.931E-08 | CYP1A2, CYP2A13, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.364E-10 | 1.650E-07 | CYP1A2, CYP2A13, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 1.019E-09 | 1.009E-06 | CYP2A13, CYP2A6, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 6.403E-09 | 5.577E-06 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 6.754E-09 | 5.656E-06 | CYP1A2, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 1.977E-08 | 1.435E-05 | CYP2A13, CYP2A6, CYP2C19 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 7.770E-08 | 4.834E-05 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008389; coumarin 7-hydroxylase activity | 1.126E-07 | 6.625E-05 | CYP2A13, CYP2A6 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 3.377E-07 | 1.793E-04 | CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 6.752E-07 | 3.267E-04 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 5.059E-06 | 2.203E-03 | CYP1A2, CYP2C19 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 4.736E-05 | 1.875E-02 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
CC | Unclassified; | GO:0031143; pseudopodium | 6.145E-03 | 9.697E-01 | MAPK1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 8.808E-12 | 5.766E-10 | CYP2A6, CYP2D6, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.177E-11 | 5.766E-10 | CYP2A6, CYP2A13, CYP2D6, CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.136E-11 | 6.978E-10 | CYP2A6, CYP2A13, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 9.556E-08 | 2.341E-06 | CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.136E-06 | 1.856E-05 | CYP2A6, CYP1A2, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 5.887E-06 | 8.241E-05 | CYP2D6, MAPK1, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.079E-04 | 1.322E-03 | CYP2A6, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 4.409E-04 | 4.321E-03 | CYP2A6, CYP1A2, CYP2C19, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.720E-04 | 1.872E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.050E-06 | 1.856E-05 | CYP2A6, CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|